HomeClinical TopicsNew combination drug treatment may successfully treat cystic fibrosis

New combination drug treatment may successfully treat cystic fibrosis

A combination of the drugs Kalydeco (ivacaftor) and lumacaftor, which has not yet been approved by the Food and Drug Administration (FDA), can successfully treat the underlying cause of cystic fibrosis for patients age 12 and older with two copies of the F508del gene mutation (the most common form of the disease), according to two phase 3 clinical trials published in the New England Journal of Medicine. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

Couple talking to NP

Getting Covid Vaccine Won’t Hurt Pregnancy Chances; Getting Covid Could

Couples planning a pregnancy might be relieved to know that getting a Covid vaccine does not hurt their odds of conceiving, according to the...